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SHOULD FOREIGN SALES EXHAUST U.S. PATENT RIGHTS POST 
QUANTA? 
INTRODUCTION 
In 1947, intellectual property made up less than ten percent of U.S. 
exports, but by the mid-1990’s intellectual property grew to account for over 
fifty percent of all U.S. exports.1  As the world has become flatter in terms of 
international trade,2 the exportation of intellectual property in the form of 
foreign sales of articles embodying U.S. patents and international technology 
licenses has grown substantially.  In 2004, royalties and licensing fees 
accounted for approximately $52.6 billion worth of payments into the United 
States from abroad.3  As these international sales and licenses have grown, it is 
now more important than ever for patent holders to have a clear understanding 
of how these international sales and licenses affect their patent rights within 
the United States when products embodying their patent are imported from 
abroad into the United States. 
Under the doctrine of patent exhaustion, if a patent holder sells a product 
that substantially embodies a patent, the patent holder’s right to restrict the use 
of the good is exhausted.4  As stated by the Supreme Court in Chaffee v. 
Boston Belting Co.: 
 
 1. FRED WARSHOF SKY, THE PATENT WARS 6 (1994)), available at http://jtlp.org/vol1/ 
gikkas.html; Nicolas S. Gikkas, International Licensing of Intellectual Property: The Promise 
and the Peril, 1 J. TECH. L. & POL’Y 6, ¶ 2 (1996) (citing U.S. CENSUS BUREAU, U.S. DEP’T 
COMMERCE, STATISTICAL ABSTRACT OF THE UNITED STATES 1951 (1952)). 
 2. See THOMAS L. FRIEDMAN, THE WORLD IS FLAT: A BRIEF HISTORY OF THE TWENTY-
FIRST CENTURY 217 (2005) (explaining that in a flattened world companies can do one of three 
things with an innovation: patent the invention and sell it themselves, patent the invention and 
license it to someone else to manufacture, or patent the invention and cross-license it with other 
companies “so that they all have freedom of action to make a product—like a PC—that comes 
from melding many different patents”). 
 3. DANIEL C.K. CHOW & THOMAS J. SCHOENBAUM, INTERNATIONAL TRADE LAW: 
PROBLEMS, CASES, AND MATERIALS 17 (2008) (from 1995 through 2004 the receipt of payments 
into the United States in international trade in the form of royalties and licensing fees has grown 
from $30.3 billion per year to $52.6 billion per year). 
 4. United States v. Univis Lens Co., 316 U.S. 241, 249 (1942) (“An incident to the 
purchase of any article, whether patented or unpatented, is the right to use and sell it, and upon 
familiar principles the authorized sale of an article which is capable of use only in practicing the 
patent is a relinquishment of the patent monopoly with respect to the article sold.”). 
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By a valid sale and purchase, the patented machine becomes the private 
individual property of the purchaser, and is no longer protected by the laws of 
the United States, but by the laws of the state in which it is situated.  Hence it 
is obvious, that if a person legally acquires a title to that which is the subject of 
letters patent, he may continue to use it until it is worn out, or he may repair it 
or improve upon it, as he pleases, in the same manner as if dealing with 
property of any other kind.5 
In addition to situations where the patent holder sells an article embodying a 
patent, the doctrine of patent exhaustion also applies when an authorized 
licensee sells such an article.6  In a line of cases following Jazz Photo Corp. v. 
International Trade Commission,7 the Court of Appeals for the Federal Circuit 
has consistently held that foreign sales of products covered by a U.S. patent do 
not exhaust the patent holder’s U.S. patent rights with respect to those 
products.8 
In general, the Federal Circuit has been relatively liberal in finding that 
patent holders could prevent the exhaustion of their patent rights by various 
means.9  In Quanta Computer, Inc. v. LG Electronics, Inc., the United States 
Supreme Court began a trend of reeling in the expansion of these methods of 
preventing patent exhaustion.10  Following this trend, on March 13, 2009, 
Northern District of California Judge Claudia Wilken ruled that U.S. patent 
rights were exhausted by foreign sales or licenses in the case of LG 
Electronics, Inc. v. Hitachi, Ltd.11 
While the LG Electronics, Inc. decision is not binding in other 
jurisdictions, it does exemplify the trend of restricting the ability of patent 
holders to prevent the exhaustion of patent rights after selling articles 
embodying their patents.12  Still, this decision flies in the face of the precedent 
 
 5. 63 U.S. (22 How.) 217, 223 (1859). 
 6. Intel Corp. v. ULSI Sys. Tech., Inc., 995 F.2d 1566, 1568 (Fed. Cir. 1993) (explaining 
that the doctrine of patent exhaustion “applies similarly to a sale of a patented product 
manufactured by a licensee acting within the scope of its license”). 
 7. 264 F.3d 1094,1105 (Fed. Cir. 2001) (“United States patent rights are not exhausted by 
products of foreign provenance.”). 
 8. See, e.g., Fuji Photo Film Co. v. Jazz Photo Corp., 394 F.3d 1368, 1376 (Fed. Cir. 2005) 
(“The patentee’s authorization of an international first sale does not affect exhaustion of that 
patentee’s rights in the United States.”). 
 9. See, e.g., Monsanto Co. v. Scruggs, 459 F.3d 1328, 1336 (Fed. Cir. 2006) (concluding 
that when a licensed manufacturer sold patented genetically modified seeds to unauthorized 
farmers such sales were unauthorized, thus avoiding exhaustion of the patent holder’s rights); 
Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 701 (Fed. Cir. 1992) (concluding that a patent 
was not exhausted when a “single use only” notice was affixed to the article being sold).  
 10. 553 U.S. 617, 638 (2008). 
 11. 655 F. Supp. 2d 1036, 1047 (N.D. Cal. 2009). 
 12. See Quanta Computer, Inc., 553 U.S. at 621 (holding that the exhaustion doctrine is 
applicable to method patents and therefore an authorized sale will exhaust the patent); Static 
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previously established by the Federal Circuit.13  The court in LG Electronics, 
Inc., in interpreting the Quanta decision, found the Supreme Court was 
“unequivocal in stating that the ‘authorized sale of an article that substantially 
embodies a patent exhausts the patent holder’s rights and prevents the patent 
holder from invoking patent law to control postsale use of the article.’”14  In 
noting that “authorized sale” could be interpreted broadly to include 
“authorized foreign sales,” the LG Electronics, Inc. Court found that the 
authorized foreign sale of articles embodying U.S. patents exhausted the patent 
holder’s U.S. patent rights on those articles.15  Such a line of reasoning would 
therefore imply that the Supreme Court in Quanta was in effect overruling the 
Federal Circuit decisions in the Jazz Photo line of cases sub silentio. 
Still, at least one other district has chosen not to apply LG Electronics, 
Inc., instead continuing to follow the Federal Circuit’s holding in Jazz Photo.16  
These holdings have created a split in how U.S. patent rights are treated when 
products are sold or licensed abroad.  Such district splits create confusion in 
the law; allowing an issue that should be handled uniformly throughout the 
U.S. court systems to instead be decided by what district the case is filed in.  
Therefore, the question of whether foreign sales exhaust U.S. patent rights is 
ripe for review by the appellate courts.  In light of this split between districts, 
the Federal Circuit or the Supreme Court needs to clarify whether foreign sales 
or licenses exhaust U.S. patents. 
This paper will argue that not only does this district split need to be 
addressed, but also, that foreign sales and licenses should not be found to 
exhaust U.S. patent rights.  There are valid arguments as to why foreign sales 
should exhaust a U.S. patent holder’s rights in articles that the patent holder 
authorized to be sold abroad, but there are even stronger policy reasons as to 
why such sales should not exhaust U.S. patents. 
Part I of this paper will provide a history on the development of the 
doctrine of patent exhaustion.  In Part II, this paper will review the treatment of 
patent exhaustion for articles sold abroad.  Part III will discuss the need for 
appellate review to clarify this area of law.  Finally, in Part IV, this paper will 
argue that foreign sales and licenses should not exhaust a U.S. patent. 
 
Control Components, Inc. v. Lexmark Int’l, Inc, 615 F. Supp. 2d 575, 582 (E.D. Ky. 2009) 
(holding that post-sale restrictions based in patent law are not enforceable). 
 13. See, e.g., Jazz Photo Corp. v. Int’l Trade Comm’n, 264 F.3d 1094, 1105 (Fed. Cir. 2001). 
 14. LG Elecs., Inc., 655 F. Supp. 2d at 1044 (quoting Quanta Computer, Inc., 553 U.S. at 
638). 
 15. Id. 
 16. Fujifilm Corp. v. Benun, No. 05-cv-1863 (KSH), 2009 WL 2232523, at *3 (D.N.J. July 
24, 2009). 
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I.  THE HISTORY AND DEVELOPMENT OF THE DOCTRINE OF PATENT EXHAUSTION 
A. Development of the doctrine of patent exhaustion 
Under 35 U.S.C. § 271, U.S. patent law provides patent holders the 
exclusive rights to make, use, or sell any patented invention within the United 
States.17  If taken literally this statute would prevent a purchaser from 
repairing, reselling, or even using an article embodying an invention without 
permission from the patent holder, even if the article was purchased directly 
from the patent holder.18  To prevent such a result, the judiciary developed a 
doctrine whereby the patent holder’s rights in an article are exhausted by the 
authorized sale of such an article. 
The origin of the patent exhaustion doctrine can be traced to Bloomer v. 
McQuewan.19  In Bloomer, the defendants in the patent infringement case 
obtained a license from the patentee to make and use patented machines for the 
duration of the patent term.20  At some point after this license was granted, but 
prior to the patent’s expiration, Congress extended the statutory length of 
patent terms.21  The defendant license holder thus sought to continue using the 
licenses through the extended term, while the patent holder tried to restrict the 
length of the license to the original patent term.22  The Supreme Court held that 
when the machines were licensed or sold to a purchaser they were “no longer 
within the limits of the [patent] monopoly” and were instead “private, 
individual property” no longer protected by the U.S. patent laws.23 
In Chaffee v. Boston Belting Co., the inventor of an improved process to 
manufacture rubber assigned the rights to the patent to an assignee.24  The 
assignee brought a patent infringement lawsuit against defendants who claimed 
that they had previously received a license from the original patent holder.25  
The lower court found for the defendants based on the legal standard that a 
purchaser of machinery had the right to continue to the use of the machinery in 
 
 17. 35 U.S.C. § 271(a) (2006) (“Except as otherwise provided in this title, whoever without 
authority makes, uses, offers to sell, or sells any patented invention, within the United States or 
imports into the United States any patented invention during the term of the patent therefore, 
infringes the patent.”). 
 18. See id. 
 19. 55 U.S. (14 How.) 539 (1852). 
 20. Id. at 547.  Patents only provide the patent holder exclusive use of an invention for a 
limited term.  The current term for a U.S. patent is twenty years from the filing date of an 
application.  35 U.S.C. § 154(a)(2) (2006). 
 21. Bloomer, 55 U.S. (14 How.) at 547. 
 22. Id. at 548. 
 23. Id. at 549–50. 
 24. 63 U.S. (22 How.) 217, 219–20 (1859). 
 25. Id. at 220. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
2011] SHOULD FOREIGN SALES EXHAUST U.S. PATENT RIGHTS POST QUANTA? 717 
conformity with the sale terms.26  The Supreme Court upheld the doctrine that 
the valid purchase of a patented article made that article the private property of 
the purchaser and stripped the patent holder of any rights in that article.27  Still, 
the Court reversed the lower court decision, finding that there had been an 
improper assumption that the defendants had obtained any license in the first 
place, as there was no evidence provided to support the contention that the 
defendant had purchased such rights.28  With this holding the Court added to 
what is now known as the doctrine of exhaustion by emphasizing that the 
patented article must have been rightfully passed to the purchaser from “the 
patentee, or from any other person by him authorized to convey it.”29 
Over time the Federal Circuit had allowed the patent holders to use various 
means to prevent their patents from being exhausted through the sale of articles 
embodying them.  In Mallinckrodt, Inc. v. Medipart, Inc.,30 the Federal Circuit 
found that when medical devices with a “single use only” notice inscribed on 
them were sold, the patent covering the devices was not exhausted as towards 
the devices being reusable.31  The court found that if a patented product was 
used in violation of a valid restriction the patent holder could seek a remedy 
under patent law.32 
In Monsanto v. Scruggs, the holder of patents for genetically modified 
soybean and cotton licensed their patents to seed manufacturing companies.33  
The licensing agreement required that the seeds could only be sold to farmers 
who had signed licensing agreements of their own, agreeing not to retain seeds 
from one generation of crops to plant in subsequent crops.34  When a farmer 
who had not signed an agreement was sued by the patent holder for retaining 
the seeds from his crops,35 the Federal Circuit found that the patent was not 
 
 26. Id. at 221. 
 27. Id. at 223. 
 28. Id. at 222–23. 
 29. Chaffee, 63 U.S. (22 How.) at 223. 
 30. 976 F.2d 700 (Fed. Cir. 1992). 
 31. Id. at 701, 709. 
 32. Id. at 709 (“If the sale . . . was validly conditioned under the applicable law such as the 
law governing sales and licenses, and if the restriction on reuse was within the scope of the patent 
grant or otherwise justified, then violation of the restriction may be remedied by action for patent 
infringement.”).  See also id. at 703 (“This right to exclude may be waived in whole or in part.  
The conditions of such waiver are subject to patent, contract, anti-trust, and any other applicable 
law, as well as equitable considerations such as are reflected in the law of patent misuse.  As in 
other areas of commerce, private parties may contract as they choose, provided that no law is 
violated thereby.”). 
 33. 459 F.3d 1328, 1333 (Fed. Cir. 2006). 
 34. Id. 
 35. Id. 
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exhausted as the seed companies were not authorized to sell seeds to the farmer 
without obtaining a signed licensing agreement from the farmer.36 
B. Quanta Computer Inc. v. LG Electronics Inc.: Pulling Back the Protection 
From Patent Exhaustion 
In Quanta Computer, Inc. v. LG Electronics, Inc., the United States 
Supreme Court pulled back some of the protections against patent 
exhaustion.37  In Quanta, the owner of patents for various methods of 
computer processing attempted to prevent their patents from being exhausted 
when Intel—an authorized licensee—sold computer chips that embodied the 
patents to third party computer manufacturers.38  Intel’s licensing agreement 
with the patent holder contained a clause explicitly disclaiming the grant of 
any implied license to Intel’s customers who purchased the chips.39  Further, 
under the terms of its license, Intel was required to inform its customers that 
the purchase of the computer chips did not create an implied license to 
combine the chips with other computer components as to practice the patent.40 
When the patent holder sued the third party computer manufacturers, the 
defendant computer manufacturers claimed that the patent was exhausted since 
they had purchased the chips from a licensed manufacturer.41  The patent 
holder contended its method patent could not be exhausted with the purchase 
of the computer chips since the subject of the patent was for a method of 
performing computing processes rather than the device performing it.42  
Further, the plaintiff patent holder claimed that its patent could not be 
exhausted because their licensing agreement with Intel explicitly denied the 
grant of any implied license to third party purchasers.43 
When the patent holder brought the infringement suit, the district court 
granted summary judgment for the defendants, finding that the license to Intel 
resulted in patent exhaustion for computer chips legitimately purchased from 
Intel.44  In a subsequent order, the district court limited its summary judgment 
ruling, finding that patent exhaustion did not apply to process or method claims 
that describe operations to make or use a product.45  Upon appeal, the Federal 
 
 36. Id. at 1336. 
 37. 553 U.S. 617 (2008). 
 38. Id. at 623–24. 
 39. Id. 
 40. Id. 
 41. Id. at 624, 628. 
 42. Quanta Computer, Inc., 553 U.S. at 628. 
 43. Id. at 636. 
 44. LG Elecs., Inc. v. Asustek Computer, Inc.,  65 U.S.P.Q. 2d (BNA) 1588, 1601 (N.D. 
Cal. 2002), rev’d, 453 F.3d 1364 (Fed. Cir. 2006), rev’d, 553 U.S. 617 (2008). 
 45. LG Elecs., Inc. v. Asustek Computer, Inc., 248 F. Supp. 2d 912, 918 (N.D. Cal. 2003), 
rev’d, 453 F.3d 1364 (Fed. Cir. 2006), rev’d, 553 U.S. 617 (2008). 
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Circuit confirmed the district court ruling that the doctrine of patent exhaustion 
did not apply to method claims and reversed the lower court in finding that the 
patent holder’s patents were not exhausted, as the components were not being 
used in the manner authorized within the licensing agreement.46 
The Supreme Court found that a method patent was indeed exhausted by 
the authorized purchase of an article embodying the patent.47  Further, the 
Court found that the license agreement did not actually impose any conditions 
on the sale of the chips to the third party computer manufacturers.48  The Court 
pointed out that nothing in the license agreement restricted Intel from selling 
the computer chips to computer manufacturers intending to practice the 
patent.49  While the license agreement stipulated that purchasers of the 
computer chips were not receiving an implied licensed to practice the patent, 
the Court held that whether these purchasers received an implied license was 
irrelevant since the third party purchasers’ right to practice the patent was 
based on patent exhaustion rather than an implied license.50  As a result, even 
in the absence of an implied license, the authorized sale of the computer chips 
embodying the patented method was found to have exhausted the patents.51 
II.  PATENT EXHAUSTION AND FOREIGN SALES 
A. Prior Rulings on the Effect of Foreign Sales on Patent Exhaustion 
The grandfather of patent of cases holding that sales outside of the United 
States do not exhaust U.S. patents is the 1890 Supreme Court case, Boesch v. 
Graff.52  Boesch was a patent infringement case where a patent holder sued an 
importer of infringing gas lamps purchased in Germany.53  The patent holder 
held a patent in Germany, but the Imperial Patent Law of Germany at the time 
allowed that if a person was already using or preparing to use an invention at 
the time the application for the patent was applied for, that person could 
 
 46. LG Elecs., Inc. v. Bizcom Elec., Inc., 453 F.3d 1364, 1369–70 (Fed. Cir. 2006). 
 47. Quanta Computer, Inc., 553 U.S. at 628–29.  An article was described as embodying a 
method patent when there would be no use for the article other than to practice the patented 
method.  Id. at 631 (citing United States v. Univis Lens Co., 316 U.S. 241, 249 (1942)). 
 48. Id. at 636–37 (“Nothing in the License Agreement restricts Intel’s right to sell its 
microprocessors and chipsets to purchasers who intend to combine them with non-Intel parts.  It 
broadly permits Intel to ‘make, use, [or] sell’ products free of LGE’s patent claims. . . .  Hence, 
Intel’s authority to sell its products embodying the LGE Patents was not conditioned . . . on 
Quanta’s decision to abide by LGE’s directions in that notice.”) (citation omitted). 
 49. Id. at 636. 
 50. Id. at 637. 
 51. Id. 
 52. 133 U.S. 697, 703 (1890). 
 53. Id. at 698–99. 
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continue to use the invention without regard to the patent.54  As such, a 
German competitor was authorized to make and sell the otherwise infringing 
gas lamps, as they had made preparations to manufacture the gas lamps prior to 
the patent holder’s filing of the application.55  The importer of the gas lamps 
contended that since his purchase of the gas lamps was authorized under 
German law that he was not infringing the patent holder’s rights by importing 
the gas lamps into the United States to resell.56 
The Court addressed whether an importer could purchase articles subject to 
a U.S. patent in another country, from a person authorized by law to sell the 
articles there, and then import them to the United States without the consent of 
the U.S. patent holder.57  The Court found that such an act infringed the U.S. 
patent, holding that “[t]he sale of articles in the United States under a United 
States patent cannot be controlled by foreign laws.”58  Whether this holding 
was limited to its facts in terms of the original sale being authorized by the 
foreign country’s law, but not the patent holder, was not entirely clear.59 
The Jazz Photo line of cases represents the modern view on whether 
foreign sales exhaust U.S. patent rights.60  The cases revolved around whether 
it was patent infringement for companies to refurbish in foreign facilities 
patented single-use, disposable cameras after they had been used by customers 
and import them into the United States to sell.61  The companies refurbishing 
these cameras claimed that the patents on the cameras had been exhausted 
through their first sale and that they were merely performing permissible 
repair.62  The patent holders claimed that there was impermissible 
 
 54. Id. at 701. 
 55. Id. at 701–02. 
 56. Id. at 699. 
 57. Boesch, 133 U.S. at 702–03. 
 58. Id. at 703. 
 59. Prior to being clarified by the Federal Circuit, courts had gone both ways.  See, e.g., 
Griffin v. Keystone Mushroom Farm, Inc., 453 F. Supp. 1283, 1286–87 (E.D. Pa. 1978) (finding 
that foreign sales failed to exhaust a patent holders U.S. patent rights, even if the sale was made 
by the patent holder or an authorized licensee of the patent holder).  But see Curtiss Aeroplane & 
Motor Corp. v. United Aircraft Eng’g Corp., 266 F. 71, 78 (2d Cir. 1920) (finding that if the 
patent holder sells a patented article, “that article is freed from the monopoly of any patents which 
the vendor may possess,” regardless of whether the sale was made in the United States or abroad); 
Kabushiki Kaisha Hattori Seiko v. Refac Tech. Dev. Corp., 690 F. Supp. 1339, 1342 (S.D.N.Y. 
1988) (finding no infringement where defendant purchased patented articles outside of the United 
States from authorized licensee). 
 60. See Fuji Photo Film Co., v. Benun, 463 F.3d 1252, 1253–54 (Fed. Cir. 2006); Jazz Photo 
Corp. v. United States (Jazz IV), 439 F.3d 1344, 1346–47, 1350 (Fed. Cir. 2006); Fuji Photo Film 
Co. v. Jazz Photo Corp. (Jazz III), 394 F.3d 1368, 1371, 1376–77 (Fed. Cir. 2005); Fuji Photo 
Film Co., v. Int’l Trade Comm’n (Jazz II), 386 F.3d 1095, 1097–98 (Fed. Cir. 2004); Jazz Photo 
Corp. v. Int’l Trade Comm’n (Jazz I), 264 F.3d 1094, 1098, 1105 (Fed. Cir. 2001). 
 61. See, e.g., Jazz I, 264 F.3d at 1098. 
 62. Id. at 1101. 
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reconstruction63 and even if the refurbishment was permissible that there was 
an implied license that the cameras were for a single use only.64 
The Federal Circuit found that with respect to cameras originally sold in 
the United States, the patent was exhausted.65  Citing Boesch, the court held 
that under the doctrine of patent exhaustion, the authorized first sale of the 
good “must have occurred under the United States patent.”66  Therefore, for 
any cameras whose original sale was outside of the United States, the patent 
holder’s U.S. patent rights were not exhausted and any importation of such a 
camera was an infringing act.67 
B. LG Electronics, Inc. v. Hitachi, Ltd.: One Federal District Court’s View 
of the Effect of Foreign Sales on Patent Exhaustion Post-Quanta 
Following the Supreme Courts holding in Quanta, multiple district courts 
have taken the Quanta decision as a signal to reel in exceptions to the doctrine 
of patent exhaustion.68  In LG Electronics, Inc. v. Hitachi, Ltd., the United 
States District Court for the Northern District of California applied the trend of 
reducing exceptions to the doctrine of patent exhaustion to articles licensed or 
sold outside of the United States.69 
LG Electronics, Inc. was essentially a continuation of the litigation 
described earlier in Quanta.  LG Electronics, Inc., involved the same plaintiff 
and essentially the same facts as in Quanta.70  Although the some of the 
 
 63. See id.  For an example of a case where patent holder argued impermissible 
reconstruction, see Aro Manufacturing Co. v. Convertible Top Replacement Co., 365 U.S. 336, 
346 (1961) (“The decisions of this Court require the conclusion that reconstruction of a patented 
entity, comprised of unpatented elements, is limited to such a true reconstruction of the entity as 
to ‘in fact make a new article’. . . .  Mere replacement of individual unpatented parts, one at a 
time, whether of the same part repeatedly or different parts successively, is no more than the 
lawful right of the owner to repair his property.”) (citation omitted). 
 64. Jazz I, 264 F.3d at 1107. 
 65. Id. at 1105. 
 66. Id. (citing Boesch v. Graff, 133 U.S. 697, 701–03 (1890)). 
 67. Id. 
 68. See, e.g., LG Elecs., Inc. v. Hitachi, Ltd., 655 F. Supp. 2d 1036, 1046 (N.D. Cal. 2009) 
(finding Quanta foreclosed the Fuji Photo exception that patents were not exhausted by an 
authorized foreign sale); Static Control Components, Inc. v. Lexmark Int’l, Inc., 615 F. Supp. 2d 
575, 586 (E.D. Ky. 2009) (finding that while an earlier Federal Circuit decision found patent 
infringement when the patent holder had not yet received its full value of the patent, the Quanta 
decision closed this exception; a sale, regardless of whether the patent holder received a full 
reward for its product, was unconditional and patent exhaustion applied). 
 69. LG Elecs., Inc., 655 F. Supp. 2d at 1046. 
 70. See id. at 1038–39 (“The same patents were the subject of litigation in this Court 
between LGE and a number of computer manufacturers.  That litigation was eventually appealed 
to the United States Supreme Court.”). 
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patents involved were different than those in Quanta,71 once again, the patent 
holder licensed its patents to Intel under an agreement containing a clause 
explicitly disclaiming the grant of any implied license to Intel’s customers.72 
Having already lost in Quanta, the plaintiff tried to distinguish the conflict.  
The plaintiff argued that because the sales by Intel took place abroad, the first 
sale of the components should not have exhausted the U.S. patent rights on 
those articles.73  The defendant computer manufacturers contended in return 
that Quanta also applied to foreign sales and that even if Quanta did not apply 
to foreign sales, the relevant sale took place in the United States, as that was 
where the license was entered into.74 
In determining whether the U.S. patents were exhausted by the foreign sale 
of the components, the court acknowledged that Quanta did not specifically 
address whether its holding pertained to foreign sales.75  Still, the court found 
that Quanta’s “unequivocal” statement that the “authorized sale of an article 
that substantially embodies a patent exhausts the patent holder’s rights and 
prevents the patent holder from invoking patent law to control postsale use of 
the article” applied to foreign sales.76  Based on the Supreme Court’s rationale 
of preventing an  “end-run” around the patent exhaustion doctrine, Northern 
District of California Judge Claudia Wilken held that the Supreme Court meant 
for “authorized sales” to include “authorized foreign sales.”77  In particular, the 
court felt that ruling that an authorized foreign sale did not exhaust an article’s 
U.S. patent rights would allow a patent holder to reap the benefit of its patent, 
yet turn around and sue a downstream purchaser for infringement.78 
The court believed that the fact that the Quanta decision discussed foreign 
sales in a different context, while failing to separate out foreign sales in its 
holding that the authorized sale of the computer chips exhausted the patent 
rights in those chips, was evidence of the Supreme Court’s intent that all 
authorized sales—whether domestic or foreign—exhaust a patent holder’s 
 
 71. Three of the four patents were the same as in Quanta.  See id.  The fourth patent was 
included in the original district court case and Federal Circuit appeal, but was excluded from the 
Supreme Court appeal.  Id. at 1039. 
 72. Id. at 1039–40. 
 73. Id. at 1044.  The plaintiff also tried to argue that the articles sold by Intel did not 
substantially embody the patent.  Id. at 1041–42.  This argument was dismissed by the court and 
is not relevant to the topic of this paper.  See id. at 1044. 
 74. LG Elecs., Inc., 655 F. Supp. 2d at 1042. 
 75. Id. at 1044. 
 76. Id. (quoting Quanta Computer, Inc. v. LG Elecs., Inc., 553 U.S. 617, 638 (2008)) 
(internal quotation marks omitted). 
 77. Id. at 1038, 1046–47. 
 78. Id. at 1046. 
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rights.79  The court noted that Boesch was reconcilable with such a holding in 
that the sale there was not authorized by the U.S. patent holder.80 
In addition to holding that the authorized foreign sale of an article could 
exhaust a U.S. patent, the court also found that the location of the authorized 
sales was within the United States.81  The court noted that the licensing 
agreement with Intel was entered into within the United States and was 
governed by New York law.82  As the patent holder received its reward for the 
use of the patent when it entered the licensing agreement, the court held that 
the licensing agreement was the relevant first sale for the purposes of patent 
exhaustion.83  As the licensing agreement was entered into within the United 
States, the court found that the relevant sale for patent exhaustion purposes had 
occurred within the United States 84 
III.  THE FEDERAL CIRCUIT OR THE SUPREME COURT NEEDS TO CLARIFY 
WHETHER FOREIGN SALES OR LICENSES EXHAUST U.S. PATENTS 
While LG Electronics, Inc. v. Hitachi, Ltd. was only a district court case 
lacking the precedential effect of an appellate level opinion, there are serious 
future implications that arise from the court’s finding that authorized foreign 
sales exhaust a U.S. patent holder’s rights.  The Northern District of California 
is a district with a large patent caseload.  During the twelve-month period 
ending September 30, 2008, the Northern District of California ranked fifth 
among district courts in terms of the highest number of filed patent cases.85  In 
addition, the LG Electronics, Inc. ruling on patent exhaustion through foreign 
sales has already been cited by courts in other districts.86  An attempt has even 
 
 79. LG Elecs., Inc., 655 F. Supp. 2d at 1045 (“[T]he fact that the Court was aware of foreign 
sales of the Intel parts, yet declined to limit its holding to sales in the United States, suggests that 
interpreting Quanta so as to impose such a limitation would be incorrect.”).  The Supreme 
Court’s acknowledgement of potential foreign sales was limited to a single footnote, discussing 
whether foreign use would be a substantial non-infringing use as part of the discussion as to 
whether the article computer chips embodied the method patent.  Id. (citing Quanta Computer, 
Inc., 553 U.S. at 632 n.6). 
 80. Id. at 1046–47. 
 81. Id. at 1048. 
 82. Id. 
 83. Id. at 1047–48. 
 84. LG Elecs., Inc., 655 F. Supp. 2d at 1048. 
 85. ADMIN. OFFICE OF THE U.S. COURTS, 2008 ANNUAL REPORT OF THE DIRECTOR: 
JUDICIAL BUSINESS OF THE UNITED STATES COURTS 192–205 (2009), available at http://www.us 
courts.gov/judbus2008/JudicialBusinespdfversion.pdf.  Only the District Courts for the Eastern 
District of Texas, the Central District of California, District of New Jersey, and District of 
Delaware had more cases filed during the twelve-month period ending September 30, 2008.  Id. at 
194, 197, 201. 
 86. See, e.g., Static Control Components, Inc. v. Lexmark Int’l., Inc., 615 F. Supp. 2d 575, 
588 (E.D. Ky. 2009) (stating that LG Electronics, Inc. v. Hitachi was an example of an expansive 
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been made to carry the holding that authorized foreign sales exhaust U.S. 
intellectual property rights over into copyright law.87 
So far, at least one other district court has declined to follow the Northern 
District of California’s lead.  In Fujifilm Corp. v. Benun,88 while taking note of 
the LG Electronics, Inc. decision, the District of New Jersey found that 
because the Supreme Court’s Quanta decision did not specifically address 
whether authorized foreign sales could exhaust the patent holder’s U.S. patent 
rights, the controlling law on the subject continued to be that of the Jazz Photo 
line of cases.89  As such, the District Court of New Jersey held that the foreign 
sales of patented articles failed to exhaust the patent holder’s U.S. patent rights 
in those articles.90 
As it currently stands, there is a split between two of the five most prolific 
patent jurisdictions.91  As such, litigants are incentivized to forum shop for 
district courts favorable to their case.92  Such a district split creates the type of 
confusion and lack of uniformity that led Congress to give the Federal Circuit 
appellate jurisdiction over patent cases.93  The confusion over whether or not 
foreign sales exhaust U.S. patent rights will likely grow if even more 
jurisdictions are asked to consider the issue without further guidance.  As such, 
either the Federal Circuit or the Supreme Court needs to address this question. 
 
interpretation of Quanta, although patent exhaustion through authorized foreign sales was not at 
issue); Fujifilm Corp. v. Benun, No. 05-cv-1863 (KSH), 2009 WL 2232523, at *3 (D.N.J. July 
24, 2009) (declining to apply LG Electronics, Inc. noting that it was not controlling law). 
 87. Brief for eBay Inc. as Amicus Curiae Supporting Petitioner at 8–9, Costco Wholesale 
Corp. v. Omega, S.A., 130 S. Ct. 356 (2010) (No. 08-1423), 2009 WL 1759032.  Copyright law 
recognizes the first sale doctrine, whereby the owner of a lawfully made copy of a copyrighted 
article may sell or otherwise dispose of the article.  See 17 U.S.C. § 109(a) (2006).  The Supreme 
Court has held that the importation of a copy of a protected work that was lawfully made within 
the United States was allowed under the first sale doctrine, but limited the holding to re-
importation of copies made in the United States.  See Quality King Distribs. v. L’Anza Research 
Int’l, Inc., 523 U.S. 135, 152 (1998). 
 88. Fujifilm Corp., 2009 WL 2232523.  Fujifilm Corp. is yet another entry in the Jazz Photo 
line of cases involving disposable cameras.  See id. at *1; cf. supra notes 62–63 and 
accompanying text. 
 89. Fujifilm Corp., 2009 WL 2232523, at *3. 
 90. Id. 
 91. See ADMIN. OFFICE OF THE U.S. COURTS, supra note 85, at 194, 201. 
 92. Kimberly A. Moore, Forum Shopping in Patent Cases: Does Geographic Choice Affect 
Innovation?, 83 J. PAT. & TRADEMARK OFF. SOC’Y 558, 567 (2001) (explaining that even within 
patent law, where the federal courts have exclusive jurisdiction, litigants forum shop for district 
courts that are favorable to their argument). 
 93. See 28 U.S.C. § 1295(a) (2006).  See also H.R. REP. NO. 97-312, at 41 (1981)  
(“Whatever form such guidelines for particular cases may take, the proposal would continue to 
provide a consistent jurisprudence and a uniform body of patent law created over time by the 
Court of Appeals for the Federal Circuit or by its reviewing court, the Supreme Court of the 
United States.”). 
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IV.  POLICY REASONS FOR NOT ALLOWING FOREIGN SALES AND LICENSES TO 
EXHAUST PATENT RIGHTS 
One of the primary policy reasons why foreign sales and licenses should 
not exhaust U.S. patents is that the U.S. patent system does not provide for 
extraterritorial effects.94  This has two separate effects.  First, U.S. patents 
provide no protection for articles sold outside of the United States.95  Second, 
the inventor must rely on each separate country’s own patent system, under 
which the inventor may not have equivalent rights, if he wants protection 
outside of the United States.96  Additionally, the established status quo is that 
U.S. patent rights are not exhausted by foreign sales, and to move away from 
the status quo would disrupt current business practices. 
A. U.S. Patents Provide No Protection for Articles Sold Outside of the 
United States 
As the court in LG Electronics, Inc. stated, the purpose of the doctrine of 
patent exhaustion is to prevent a patent holder from enforcing its patent rights 
against downstream purchasers after having already “reap[ed] the benefit of its 
patent.”97  The court made a point within its holding to emphasize that the 
initial sales of the patented devices were authorized by the U.S. patent holder. 
98  As such, the patent holder had reaped its benefit.  Still, whether or not the 
sale was authorized by the patent holder does not displace the fact that the sale 
takes place outside of the jurisdiction of U.S. patent law. 
The U.S. patent laws provide that anyone who makes, uses, or sells a 
patented invention “within the United States” or imports a patented invention 
“into the United States” without the authorization of the patent holder is 
infringing the invention.99  It is also infringement to export components or 
devices that can only be used to practice a patented invention from the United 
 
 94. See Deepsouth Packing Co. v. Laitram Corp., 406 U.S. 518, 531 (1972) (confirming that 
the patent system “makes no claim to extraterritorial effect”), abrogated in part by 35 U.S.C. § 
271(f) (2006), with respect to components made within the United States for sale abroad that 
could only be used to practice an invention protected by a U.S. patent; Rotec Indus., Inc. v. 
Mitsubishi Corp., 215 F.3d 1246, 1251 (Fed. Cir. 2000) (quoting Dowagiac Mfg. Co. v. Minn. 
Mowline Plow Co., 235 U.S. 641, 650 (1915)) (noting “[t]he right conferred by a patent under 
our law is confined to the United States and its territories” and that infringement of U.S. patents 
“cannot be predicated on acts wholly done in a foreign country”). 
 95. Deepsouth Packing Co., 406 U.S. at 531; Rotec Indus., Inc., 215 F.3d at 1251. 
 96. See Randy L. Campbell, Note, Global Patent Law Harmonization: Benefits and 
Implementation, 13 IND. INT’L & COMP. L. REV. 605, 619 (“[W]hat constitutes a patentable 
subject matter varies among nations.”). 
 97. LG Elecs., Inc. v. Hitachi, Ltd., 655 F. Supp. 2d 1036, 1046 (N.D. Cal. 2009). 
 98. Id. at 1048. 
 99. 35 U.S.C. § 271(a) (2006). 
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States.100  Still, the key to a finding of infringement is that there must have 
been an act committed within the United States. 
There is no protection from acts committed solely outside of the United 
States.101  As such, an article that is manufactured, sold, and used outside of 
the United States falls completely outside of the jurisdiction of U.S. patent 
laws.102  Therefore, allowing sales outside of the United States to exhaust 
United States patents would strip patent holders of a protection that they never 
had in the first place. 
B. U.S. Patent Holders May Not Have Equivalent Protection for Their 
Invention Abroad 
The fact that U.S. patent laws do not provide a patent holder protection 
abroad would not be as much of an issue if foreign jurisdictions always 
provided U.S. patent holders equivalent protection.  As will be discussed, the 
rights conferred by foreign jurisdictions may differ substantially.103  Further, it 
is possible that the U.S. patent holder will choose not to pursue patent 
protection—or may not even be eligible for protection—in these foreign 
jurisdictions.104  For sales in a country outside of the United States, the 
inventor must avail himself to that country’s applicable patent laws.105  By 
virtue of the invention not being protected by U.S. patent laws, the inventor or 
his assignee may be dealing from a drastically different bargaining position 
when selling their products outside the United States than they would be 
dealing from within the United States.106 
 
 100. Id. § 271(f). 
 101. See Deepsouth Packing Co. v. Laitram Corp., 406 U.S. 518, 527 (1972) (citing 35 U.S.C. 
§ 271 (1970)). 
 102. See id. (citing 35 U.S.C. § 271 (1970) (“The statute makes it clear that it is not an 
infringement to make or use a patented product outside of the United States.”)); Brown v. 
Duchesne, 60 U.S. (19 How.) 183, 195 (1856) (noting U.S. patent laws “do not, and were not 
intended to, operate beyond the limits of the United States”). 
 103. See infra notes 160–81 and accompanying text. 
 104. See infra notes 113–59 and accompanying text. 
 105. See Microsoft Corp. v. AT&T Corp., 550 U.S. 437, 455–56 (2007) (holding that AT&T 
needed to rely on foreign law to prevent foreign infringement).  “Foreign conduct is generally the 
domain of foreign law, and in the area here involved, in particular, foreign law may embody 
different policy judgments about the relative rights of inventors, competitors, and the public in 
patented inventions.”  Id. at 455 (internal quotations and citations removed). 
 106. See Michele L. Vockrodt, Patent Exhaustion And Foreign First Sales: An Analysis And 
Application Of the Jazz Photo Decision, 33 AIPLA Q.J. 189, 202 (2005) (quoting Brian D. 
Coggio & Adriane M. Antler, The Utilization of the United States Patents to Prevent the Sale of 
Gray Goods, 83 TRADEMARK REP. 481, 494 (1993); citing Hilary A. Kremen, Note, Caveat 
Venditor: International Application of the First Sale Doctrine, 23 SYRACUSE J. INT’L L. & COM. 
161, 163 (1997) (explaining that since patent rights have an “independent territorial existence” 
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There is no such thing as an international patent,107 but there are 
international treaties that provide requirements for the individual countries’ 
patent regimes.  Most notable are the Paris Convention for the Protection of 
Industrial Property (Paris Convention),108 the Agreement on Trade-Related 
Intellectual Property Rights (TRIPS),109 and the Patent Cooperation Treaty 
(PCT).110 
The Paris Convention provided that each member state would grant 
equivalent rights for foreign and domestic inventors, give priority rights to 
inventors based on the date which they filed a patent application with any other 
member state, and adhere to common rules upon contracting member nations’ 
patent regimes.111  The TRIPS agreement provided general requirements on 
each member state’s patent regime in determining standards to apply in 
evaluating the patentability of an invention.112  The PCT provided a procedure 
for filing patent applications by which inventors could pursue patent protection 
with each member state.113 
While the PCT made it significantly easier to obtain a patent on an 
invention in multiple countries, each country still grants their own patents 
subject to their own requirements.114  The PCT allows an applicant to submit a 
patent application to one of three international search authorities in what is 
called the international stage.115  The international search authority then 
performs a search to find prior art that may be relevant to determine whether 
an invention is novel, involves an inventive step (is non-obvious), and is 
industrially applicable.116  The international search authority then issues a 
 
the bargained for compensation received for the sale an article is “likely to be tailored to the 
jurisdiction in which it is sold”)). 
 107. There is such a thing as a European Patent, but even this is a misnomer.  Even with a 
European Patent an inventor is required to meet the requirements of the individual nations within 
the European Union in which they seek patent protection.  Campbell, supra note 96, at 624–25. 
 108. Paris Convention for the Protection of Industrial Property, Mar. 20, 1883, 21 U.S.T. 
1583, 828 U.N.T.S. 305 (as amended on Sept. 28, 1979) [hereinafter Paris Convention]. 
 109. Agreement on Trade Related Intellectual Property Rights, Apr. 15, 1994, Marrakesh 
Agreement Establishing the World Trade Organization, Annex 1C, 1869 U.N.T.S. 299  
[hereinafter TRIPS]. 
 110. Patent Cooperation Treaty, June 19, 1970, 28 U.S.T. 7645, 1160 U.N.T.S. 231 
[hereinafter PCT]. 
 111. See Paris Convention, supra note 108, arts. 2, 4. 
 112. See TRIPS, supra note 109. 
 113. See PCT, supra note 110, ch. 1. 
 114.  U.S. PATENT & TRADEMARK OFFICE, U.S. DEP’T OF COMMERCE, MANUAL OF PATENT 
EXAMINING PROCEDURE § 1801 (8th ed. 2008) [hereinafter MPEP]. 
 115. See id. § 1801(I) (describing the procedure for Americans that wish to file an 
international PCT application).  The three international search authorities are the United States 
Patent and Trademark Office (USPTO), European Patent Office (EPO), and Korean Intellectual 
Property Office (KIPO).  Id. §§ 1840–1840.2. 
 116. PCT, supra note 110, art. 15.  MPEP, supra note 114, § 1801(III). 
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report on its findings,117 identifying prior art that may prevent the invention 
from being patentable within the member states.118 
Within thirty months of submitting a PCT application, applicants must 
decide whether they wish to enter the national stage in individual countries.119  
In the national stage, the application is sent to the different countries where the 
applicant wants to obtain a patent for review by each country’s own patent 
office.120  Within the national stage the individual countries will weigh the 
application under their own rules for patentability.121  The individual countries 
may rely on the international search report or may perform prior art searches of 
their own.122 
As the application is reviewed in each country separately, it can be 
extremely costly to seek a patent in multiple countries.  Each country will have 
its own fees to prosecute a patent.123  The applicant may be required to have 
the application translated into that country’s language, as well as conduct the 
entirety of the prosecution in that country’s language.124  Further, the applicant 
will likely have to hire local representation in each country to argue the merits 
of the application.125 
Due to these substantial costs, an inventor or an assignee of rights to the 
invention may be selective in determining in which countries to seek patents.  
It is not out of the realm of possibility that an inventor would not seek a patent 
in a country where he would expect only modest sales.126  The lack of a patent 
may lead to competition from other manufacturers or producers using the same 
 
 117. PCT, supra note 110, art. 18. 
 118. Id. art. 16, ¶ 1. 
 119. Id. art. 22, ¶ 1.  Article 22 was amended in 2002 to reflect the thirty-month limit.  
Revision of the Time Limit for National Stage Commencement in the United States for Patent 
Cooperation Treaty Applications, 67 Fed. Reg. 520, 520 (Jan. 4, 2002) (to be codified at 37 
C.F.R. pt. 1). 
 120. See PCT, supra note 110, art. 27 (detailing the requirements for national patent 
applications).  See also MPEP, supra note 114, § 1893 (describing the advantages over PCT 
national stage versus filing an application for a national patent in the United States). 
 121. PCT, supra note 110, art. 15, ¶ 5(a)–(b), art. 27, ¶ 5. 
 122. Id. art. 15, ¶ 5(a)–(b). 
 123. Daniel N. Yannuzzi, Developing a Foreign Filing Strategy, in GLOBAL PATENT 
PROSECUTION 111, 117 (Eddie Foumier ed., 2009) (explaining that within each country a part 
seeking patent protection will be subject to fees such as “filing fees, examination fees, granting 
fees, and annuities or maintenance fees”). 
 124. Id. (“This means that not only does the initial application need to be translated, but also 
subsequent correspondence with the patent office may need to be translated such that the 
company and its U.S. attorneys can participate with local foreign counsel in prosecution 
activities.  These translation fees can be extremely expensive and add dramatically to the cost of 
seeking and obtaining patent protection in foreign jurisdictions.”). 
 125. Id. 
 126. Id. at 126. 
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invention in their products.127  Such competition would be in stark contrast to 
the monopoly over the invention given to the patent holder within the United 
States.  By holding a monopoly on an invention, the patent holder may be able 
to charge higher prices when selling its patented products within the United 
States; in foreign markets it may be restricted to the price obtainable under 
perfect competition.128  If the foreign sale of an article embodying a U.S. 
patent is found to exhaust the U.S. patent rights on the article, the door may be 
open to disrupt the patent holder’s granted monopoly within the United States.  
Foreign resellers and licensees may effectively be able to purchase or contract 
for the rights to produce articles in foreign markets at competitive—rather than 
monopolistic—prices and then import them into the United States. 
Even if a U.S. patent holder were willing to seek patent protection abroad, 
it is entirely possible that the invention—patentable within the United States—
would not even be eligible for such protection in other countries.  The current 
TRIPS regime requires that member countries make patentability available for 
inventions “in all fields of technology, provided that they are new, involve an 
inventive step and are capable of industrial application.”129  Still, each 
country’s patent system has its own requirements for patentability.  The 
differences between these requirements may seem minor at first, but the devil 
may very well be in the details. 
One of the most significant differences between various countries’ 
requirements for patentability is what inventive subject matters are eligible for 
patent protection.  The areas these differences may be most prevalent in are 
computing/business methods and biotechnology.  In the United States, 35 
U.S.C. § 101 provides a statutory patentable subject matter of “any new and 
useful process, machine, manufacture, or composition of matter.”130  The 
Supreme Court, in Diamond v. Chakrabarty, interpreted this “to include 
 
 127. But see id. (explaining that if a patent protects a product in the American and European 
markets it may not be worthwhile for a competitor to enter the market at all). 
 128. See Alan Devlin & Neel Sukhatme, Self-Realizing Inventions and the Utilitarian 
Foundation of Patent Law, 51 WM. & MARY L. REV. 897, 917 (2009) (“An inventor awarded a 
patent, in effect, is granted a monopoly over her invention, with the result that consumers cannot 
freely avail themselves of its nonrivalrous characteristics.  If the technology at issue is sufficiently 
valuable—such as if the patented invention is highly useful and has few if any substitutes—the 
monopoly that is granted becomes an economic monopoly.  As a result, the inventor will set the 
price at the point where marginal cost equals marginal revenue and charge a monopoly price, 
which exceeds what she would charge in a competitive market.”) (footnotes omitted).  See 
generally RICHARD A. POSNER, ECONOMIC ANALYSIS OF LAW 273–78 (6th ed. 2003) (detailing 
the effects that monopolistic control by a firm has on prices and outputs). 
 129. TRIPS, supra note 109, art. 27, ¶ 1. 
 130. 35 U.S.C. § 101 (2006) (“Whoever invents or discovers any new and useful process, 
machine, manufacture, or composition of matter, or any new and useful improvement thereof, 
may obtain a patent therefor, subject to the conditions and requirements of this title.”). 
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anything under the sun that is made by man.”131  While “laws of nature, 
physical phenomena, and abstract ideas are not patentable subject matter,”132 a 
wide range of computing and business methods133 and biotechnology134 
inventions have been granted U.S. patents. 
Until recently, business methods and computer software have enjoyed 
patentability within the United States so long as they produced a “useful, 
concrete, and tangible result.”135  With its ruling in In re Bilski,136 the Federal 
Circuit attempted to narrow the patentability of method claims to those 
implemented with a particular machine or that transform an article from one 
thing or state to another.137  The Supreme Court was critical of this “machine-
or-transformation test” as “the sole test for deciding whether an invention is a 
patent-eligible ‘process.’”138  Still, the Court gave significant credence to the 
test by hailing it as a “useful and important clue” in determining 
patentability.139 
 
 131. 447 U.S. 303, 309 (1980) (quoting S. REP. NO. 1979, at 5 (1952); H.R. REP. NO. 1923, at 
6 (1952)). 
 132. Parker v. Flook, 437 U.S. 584, 598 (1978) (Stewart, J., dissenting). 
 133. See, e.g., Computer-Based Commc’n Sys. & Method Using Metadata Defining a Control 
Structure, U.S. Patent No. 5,862,325 (filed Sept. 27, 1996) (issued Jan. 19, 1999); Method & Sys. 
for Generating & Auditing a Signature for a Computer Program, U.S. Patent No. 5,559,884 (filed 
June 30, 1994) (issued Sept. 24, 1996); Sys. & Method for Integrating a Bus. Env’t with a Process 
Control Env’t, U.S. Patent No. 5,463,555 (filed Sept. 28, 1993) (issued Oct. 31, 1995).  But see In 
re Bilski, 545 F.3d 943, 956, 964–66 (Fed. Cir. 2008) (rejecting the patentability of a method for 
commodity trading and implementing a new standard for patentability of business methods 
consisting of evaluating whether a method is tied to a machine or physically transforms an 
article). 
 134. See, e.g., Cancer Susceptibility Mutations of BRCA2, U.S. Patent No. 6,051,379 (filed 
Dec. 2, 1997) (issued Apr. 18, 2000); Method for Animal Cell Culture, U.S. Patent No. 5,976,833 
(filed Sept. 19, 1996) (issued Nov. 2, 1999); Method of Treating HIV in Humans by Admin. of 
DDI & Hydroxycarbamide, U.S. Patent No. 5,521,161 (filed Dec. 20, 1993) (issued May 28, 
1996). 
 135. In re Alappat, 33 F.3d 1526, 1544 (Fed. Cir. 1994), abrogated by In re Bilski, 545 F.3d 
at 943 (setting the standard by which the Federal Circuit determined whether a mathematical 
concept was patentable prior to In re Bilski).  AT&T Corp. v. Excel Commc’ns, Inc., 172 F.3d 
1352, 1357–60 (Fed. Cir. 1999), abrogated by In re Bilski, 545 F.3d at 943 (applying the standard 
set by in In re Alappat in finding that a mathematical algorithm for use in billing long distance 
phone calls was patentable).  See also State St. Bank & Trust Co. v. Signature Fin. Grp., Inc., 149 
F.3d 1368, 1373–75 (Fed. Cir. 1998), abrogated by In re Bilski, 545 F.3d at 943 (applying the 
standard set by In re Alappat in finding that a mathematical algorithm for use in compiling 
financial data was patentable). 
 136. 545 F.3d at 943. 
 137. Id. at 959–60 (concluding that the “useful, concrete and tangible result” test was 
insufficient and that the “machine-or-transformation test” was the correct test to apply in 
determining whether business or computational methods were patentable). 
 138. Bilski v. Kappos, 130 S. Ct. 3218, 3227 (2010). 
 139. Id. 
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Even under the “machine-or-transformation test” for the patentability of 
business methods and computer software, the patentability of such inventions 
within the United States is still greater than under the patent systems in some 
other countries.  Much of Europe ties patentability to inventions that actually 
make a contribution in a technical field.140  Under such a standard, technology 
is frequently restricted to that which is a physical object.141  As such, business 
methods and software are generally not patentable in Europe.142  Hostility 
toward the patentability of business methods and software is not restricted to 
just Europe, as countries like Israel, China, and India also severely restrict such 
inventions from being patented.143 
Biotechnology is another area that can differ greatly in its patentability 
within different patent jurisdictions.  While biotechnology is generally 
accepted as patentable within the United States, developing countries are 
resistant to recognizing intellectual property rights in biotechnology.144  Article 
27 of TRIPS provides that all member nations must make patent protection 
available in all fields of technology.145  Member countries may exclude from 
patentability inventions that which would (1) harm the “ordre public or 
 
 140. United Nations Convention on the Grant of European Patents (European Patent 
Convention), art. 52(1), Oct. 5, 1973, 1065 U.N.T.S. 255, available at http://www.epo.org/ 
patents/law/legal-texts/epc.html, as amended by the Act Revising the European Patent 
Convention, Nov. 29, 2000.  See also RAINER OSTERWALDER, EUROPEAN PATENT OFFICE, 
PATENTS FOR SOFTWARE?: EUROPEAN LAW AND PRACTICE 9–11 (2009) (addressing how the 
standard for patentability set by the European Patent Convention is applied to software), available 
at http://documents.epo.org/projects/babylon/eponet.nsf/0/a0be115260b5ff71c125746d004c51a5/ 
$FILE/patents_for_software_en.pdf. 
 141. Kelvin W. Willoughby, How Much Does Technology Really Matter in Patent Law? A 
Comparative Analysis of Doctrines of Appropriate Patentable Subject Matter in American and 
European Patent Law, 18 FED. CIR. B.J. 63, 95 (2009) (“The EPO’s contribution approach 
presumes that an artifact is only ‘technical’ (i.e., a technology) if it is a physical machine, or 
perhaps just simply physical.”). 
 142. See European Patent Convention, supra note 140, art. 52(2)(c) (stating that mathematical 
methods, methods for performing mental acts or doing business, and computer programs “shall 
not be regarded as inventions within the meaning of paragraph 1” of Article 52.).  See also 
Willoughby, supra note 141, at 97 (“Software inventions are generally not ‘technical’ according 
to this way of thinking. . . . the EPO’s case law has held that if the software is functionally 
embedded inside something that will hurt you if you drop it on your foot, then it may be deemed 
as ‘technical’ and hence patentable.”). 
 143. Yannuzzi, supra note 123, at 133. 
 144. Jonathan Curci, The New Challenges to the International Patentability of Biotechnology: 
Legal Relations Between the WTO Treaty on Trade-Related Aspects of Intellectual Property 
Rights and the Convention on Biological Diversity, 2 INT’L L. & MGMT. REV. 1, 2 (2005) 
(developing countries are resistant to the patentability of biotechnology fearing patentability of 
biotechnology results in control by the developed world over their access to “food, medicinal 
technology, and other resources essential to mankind’s health and welfare”). 
 145. TRIPS, supra note 109, art. 27, ¶ 1. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
732 SAINT LOUIS UNIVERSITY LAW JOURNAL [Vol. 55:713 
morality;”146 (2) pertain to “diagnostic, therapeutic and surgical methods for 
the treatment of humans or animals;”147 or (3) relate to “plants and animals 
other than micro-organisms, and essentially biological processes for the 
production of plants or animals other than non-biological and microbiological 
processes.”148 
The requirement that an invention must be novel in order to be eligible for 
a patent is fairly standard both in the United States and abroad.  The individual 
components of the novelty test within patent laws vary from country to 
country, creating circumstances where an invention could be considered 
novel—and thus patentable—within the United States, yet fail the novelty 
requirement in other countries. 
Title 35 U.S.C. § 102 provides a complicated multi-faceted test to 
determine whether an invention is novel under U.S. patent law.149  Within the 
United States, if “the invention was known or used by others in this country” 
then it is deemed to lack novelty.150  This can be better understood as a 
requirement that only the first person to invent something is eligible for a 
patent on his invention.  Notice though, that the resulting first-to-invent patent 
system has a territorial element in that a prior invention must have been known 
within the United States to defeat an applicant’s novelty.151  Following this 
rule, if another inventor were to invent something abroad first, a subsequent 
U.S. inventor may still be entitled to a U.S. patent so long as there was no 
knowledge of the invention within the United States.  Meanwhile, the majority 
of other countries have a first-to-file system, awarding patents to the first 
inventor to file an application for a patent.152  As such, if a U.S. inventor were 
the first to invent something they would be eligible for a U.S. patent, but could 
still lose out to a subsequent inventor in foreign countries by losing the race to 
file a patent application. 
Additionally, if an invention was “patented or described in a printed 
publication” anywhere in the world or was “publicly used or sold” within the 
United States more than one year prior to the date of filing an application for a 
patent, then the invention would fail the novelty test under U.S. patent laws.153  
As such, if the invention was publicly disclosed in a printed manner by 
anyone—including the inventor applying for the patent—more than a year 
before the filing of an application, the invention is not patentable.  This creates 
 
 146. Id. art. 27, ¶ 2. 
 147. Id. art. 27, ¶ 3(a). 
 148. Id. art. 27, ¶ 3(b). 
 149. 35 U.S.C. § 102 (2006). 
 150. Id. § 102(a). 
 151. Id. 
 152. Campbell, supra note 96, at 619. 
 153. 35 U.S.C. § 102(b). 
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a grace period of one year in which an inventor may apply for a patent after 
having already disclosed the invention.154 
This one-year grace period is generous compared to many of the patent 
systems found in other countries.  The Paris Convention prevents member 
countries from denying patentability on novelty grounds due to an inventor 
having disclosed an invention through the act of filing a patent application in 
another member country within the previous twelve months.155  While the 
Paris Convention essentially gives a twelve-month grace period for an inventor 
who has decided to seek patent protection elsewhere first, this grace period 
does not apply to any disclosures preceding the filing of a patent application in 
at least one member country.156 
Individual countries frequently determine their own rules for inventions 
disclosed outside of a patent application.  China allows for a six-month grace 
period for inventions disclosed at exhibitions sponsored or recognized by the 
Chinese Government, made public at prescribed academic or technological 
meetings, or disclosed without the consent of the applicant.157  European Patent 
Convention countries158 have a strict novelty requirement159and provide a 
grace period in such limited situations as to render their grace period virtually 
 
 154. Such grace periods are controversial.  On one hand, grace periods allow inventors to 
share discoveries and interact with others in the field in such a way as to promote innovation and 
growth without risk of losing their patent rights.  Renee E. Metzler, Comment, Not All Grace 
Periods Are Created Equal: Building a Grace Period From the Ground Up, 13 MARQ. INTELL. 
PROP. L. REV. 371, 376–77 (2009).  On the other hand, grace periods may allow an inventor to 
delay their filing of a patent and subsequently increase the duration of time in which they will 
have exclusive rights in the invention.  See id. at 403 (explaining that an increased grace period 
would disrupt the fair balance between an inventor and the public). 
 155. Paris Convention, supra note 108, art. 4(A), (C)(1) (noting a twelve-month grace period 
is given for inventors to seek utility patents in additional countries after having filed an 
application in an initial member country; design patents receive only a six-month grace period).  
See also Metzler, supra note 154, at 40001 (noting that the Paris Convention most benefits 
inventors who disclose their inventions for the first time in the application process). 
 156. See Metzler, supra note 154, at 401 & n.128 (noting that any disclosures made prior to 
the filing of the first patent application could be used against the applicant as prior art). 
 157. Patent Law of the People’s Republic of China (promulgated by the Standing Comm. 
Nat’l People’s Cong., Mar. 12, 1984), as amended by Decision on the Amendment of the Patent 
Law of People’s Republic of China (promulgated by the Standing Comm. Nat’l People’s Cong., 
Aug. 25, 2000, effective July 1, 2001) art. 24, translated in 1 P.R.C. LAWS & REGS II-03-03-101 
(China). 
 158. There are currently thirty-six member states of the European Patent Organization.  See 
Member states of the European Patent Organization, EUROPEAN PATENT ORG., http://www.epo. 
org/about-us/organisation/member-states.html (last visited June 20, 2011), for a list of member 
countries. 
 159. European Patent Convention, supra note 140, art. 52(1) (“European patents shall be 
granted for any inventions, in all fields of technology, provided that they are new, involve an 
inventive step and are susceptible of industrial application.”). 
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non-existent.160  In fact, the European Patent Convention specifically includes 
“everything made available to the public by means of a written or oral 
description, by use, or in any other way” prior to the filing of a European 
patent application as novelty defeating art.161 
As the novelty requirements vary significantly from country to country it is 
entirely possible that an invention that has been publicly disclosed may still be 
patentable in the United States due to the twelve-month grace period, yet be 
unpatentable due to lack of novelty in a significant portion of the world.  As 
such, it is not a given that a U.S. patent holder would have any protection for 
its intellectual property abroad. 
Even if an inventor or his assignee has a patent where the good is sold, the 
patent may be more difficult to enforce.162  Therefore, the patent holder may 
have substantially less bargaining power.  In order to enforce these foreign 
patents, the patent holder would still be required to avail themselves to each 
separate country’s court system in response to infringing acts within those 
jurisdictions.163  If the patent holder has to sue infringers in these various 
countries the patent holder will likely need to hire foreign counsel in each 
jurisdiction to represent them.164  Further additional cost may be necessary to 
translate any court documents and transport key witnesses to the trial 
location.165  As the difficulty to enforce a patent increases, the value of the 
patent decreases.  It is not unlikely that when facing the possibility that a 
competitor in a foreign country will infringe a patent, the patent holder may be 
better off licensing the patent to this potential infringer rather than trying to 
enforce its rights through a foreign country’s courts.  In such a situation the 
patent holder may be inclined to license the patent at a rate below what the 
patent holder would desire in the patent holder’s home jurisdiction. 
Additionally, some countries have compulsory licenses and local working 
requirements that may reduce a patent holder’s bargaining power.  Black’s Law 
Dictionary defines compulsory license as “a statutorily created license” that 
permits people to pay a royalty and use an invention without the patentee’s 
permission.166  Local working requirements are requirements that a patent 
holder manufacture or produce a patented article within the granting country’s 
 
 160. See Metzler, supra note 154, at 397 n.113 (2009) (discussing that many commentators 
have incorrectly reached the conclusion that the EPC does not provide any grace period). 
 161. European Patent Convention, supra note 140, art. 54(2). 
 162. Yannuzzi, supra note 123, at 127. 
 163. Id. at 127–28. 
 164. Id. at 127 (“It is also desirable to have local U.S. counsel (whether in-house or outside 
counsel) help manage foreign counsel and issues associated with the enforcement action.”). 
 165. Id. 
 166. BLACK’S LAW DICTIONARY 1003 (Bryan A. Garner ed., 9th ed. 2009). 
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territory or otherwise forfeit rights in the patent.167  Local working 
requirements and compulsory licenses often work hand-in-hand, as the typical 
remedy for failing to practice a local working requirement is to grant of a 
compulsory license to a local producer.168  While the United States does not 
formally recognize compulsory licenses or working requirements,169 other 
countries—particularly developing countries—do contain compulsory licenses 
or working requirements within their patent laws.170 
The TRIPS Agreement restricts member nations from granting compulsory 
licenses, with the exception of specific conditions listed within Article 31.171  
Among the conditions listed under Article 31 of the TRIPS agreement are that 
compulsory licenses must be considered on each occurrence’s individual 
merits, that the proposed grantees of compulsory licenses be required to 
attempt to negotiate a license first, that the scope and duration of any 
compulsory licenses are limited to the specific purpose for which they were 
authorized, that the use of the compulsory licenses are limited to supplying the 
granting country’s domestic market, and that adequate remuneration is 
 
 167. See Paul Champ & Amir Attaran, Patent Rights and Local Working Under the WTO 
TRIPS Agreement: An Analysis of the U.S.-Brazil Patent Dispute, 27 YALE J. INT’L L. 365, 366 & 
n.6 (2002) (describing the meaning of local working requirements); see also id. at 37073 
(describing the history of the use of local working requirements in the development of patent 
laws). 
 168. Id. at 366. 
 169. BLACK’S LAW DICTIONARY, supra note 166, at 1003 (“While some nations currently 
recognize compulsory licenses, the United States never has.”).  Commentators have noted that 
judicial remedies such as those imposed on patent holders to cure antitrust violations and awards 
of on-going reasonable royalties in lieu of an injunctions as the result of patent infringement 
certain cases are essentially compulsory licenses.  See, e.g., Joshua D. Sarnoff & Christopher M. 
Holman, Recent Developments Affecting the Enforcement, Procurement, and Licensing of 
Research Tool Patents, 23 BERKELEY TECH. L.J. 1299, 1353–55 (2008) (noting that ongoing 
royalty damage awards offered in lieu of injunctions may be considered compulsory licenses); 
Andrew C. Mace, Note, TRIPS, eBay, and Denials of Injunctive Relief: Is Article 31 Compliance 
Everything?, 10 COLUM. SCI. & TECH. L. REV. 232, 249–50 (2009) (stating commentators note 
that the United States has a long history of granting compulsory licenses in the form of judicial 
orders to remedy anti-competitive practices).  In addition, where the U.S. government is found to 
have infringed a patent, they are only held to damages and fees, essentially equating to a 
compulsory license.  See 28 U.S.C. § 1498(a) (2006) (providing monetary remedies but no 
injunction).  See also Richard J. McNeely, Governmental Indirect Patent Infringement: The Need 
to Hold Uncle Sam Accountable Under 28 U.S.C. § 1498, 36 CAP. U. L. REV. 1065, 1080 (2008) 
(“When the government infringes a patent, the government is viewed to have taken control not of 
the patent itself, but of a compulsory license to practice the patented invention.”).  The Federal 
Circuit has tried to distinguish such remedies, stating that, “‘compulsory license’ implies that 
anyone who meets certain criteria has congressional authority to use that which is licensed” as 
compared to judicially imposed remedies only pertaining to the parties in suit.”  Paice LLC v. 
Toyota Motor Corp., 504 F.3d 1293, 1313 n.13 (Fed. Cir. 2007). 
 170. Champ & Attaran, supra note 167, at 366 & n.7. 
 171. TRIPS, supra note 109, art. 31. 
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awarded to patent holders.172  Article 5A of the Paris Convention offers a few 
additional restrictions on the use of compulsory licenses.173  Article 5A 
provides that such compulsory licenses cannot be granted prior to four years 
from the filing date of a patent application or three years from the patent issue 
date, whichever is later; thus allowing a patentee adequate time to attempt to 
meet the needs of the market.174  In addition, Article 5A allows a patent holder 
to avoid compulsory licenses by showing justification for not meeting the 
market demand.175 
Local working requirements are generally not accepted within the various 
international treaties on patent rights.  The Paris Convention disallowed the 
forfeiture of patents by member countries purely on the grounds that patented 
articles are imported into that country.176  The TRIPs Agreement allows that 
“patents shall be available and patent rights enjoyable without discrimination 
as to . . . whether products are imported or locally produced.”177  Still, many 
developing countries have refused to eliminate their local working 
requirements, arguing that the exceptions within the TRIPs agreement and the 
Paris Convention for compulsory licenses apply to local working requirements 
as well.178 
Developing countries are known to use compulsory licenses and local 
working requirements to force patent holders to bring their patented products 
to market at terms favorable to the public.179  Brazil has repeatedly used the 
threat of compulsory licenses to obtain concessions from major pharmaceutical 
firms.180  The U.S. Government went so far as to bring a case before the WTO, 
challenging Brazil’s patent laws on local working requirements and 
compulsory licenses.181  Under international pressure, the U.S. Government 
withdrew the case but reserved the right to renew the complaint.182  Brazil has 
since carried through on its threat, granting a compulsory license for the 
 
 172. Id. 
 173. Paris Convention, supra note 108, art. 5A. 
 174. Id. art. 5A(4). 
 175. Id. 
 176. Id. art. 5A(1). 
 177. TRIPS, supra note 109, art. 27, ¶ 1. 
 178. Champ & Attaran, supra note 167, at 367–68. 
 179.  See Elizabeth Ferrill, Clearing the Swamp for Intellectual Property Harmonization: 
Understanding and Appreciating the Barriers to Full TRIPS Compliance for Industrializing and 
Non-Industrialized Countries, 15 U. BALT. INTELL. PROP. L.J. 137, 162–63 (2007) (describing 
threats to use compulsory licenses by South Africa, Brazil, and Nigeria to obtain concessions 
from pharmaceutical companies). 
 180. Peter K. Yu, Access to Medicines, BRICS Alliances, and Collective Action, 34 AM. J.L. 
& MED. 345, 349 (2008). 
 181. Champ & Attaran, supra note 167, at 365–66. 
 182. See id. at 366 (noting that the United States stood to lose more by “winning” the 
litigation than by abandoning it, and that the United States could still file a new complaint). 
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patented drug efavirenz as part of a program to provide free treatment of 
HIV/AIDS in 2007.183  While under TRIPs a compulsory license may only be 
used domestically,184 the mere possibility that such licenses could be granted 
creates incentives for a patent holder to price patented articles for less or accept 
less favorable terms when negotiating licenses for their technology. 
C. Not Allowing Foreign Sales to Exhaust U.S. Patent Rights is the Status 
Quo 
A final policy reason why foreign sales should not exhaust U.S. patents is 
that such a change would go against the status quo.  Allowing the foreign sale 
of articles subject to U.S. patents to exhaust U.S. patent rights may directly 
interfere with current business models and puts patent holders that have 
previously entered into licenses abroad in an unintended position. 
One example of a business model which would be affected would be that 
of the pharmaceutical industry.  Within this industry, pharmaceutical 
companies give away or sell their patented drugs at deeply reduced prices to 
third world countries.185  The pharmaceutical companies have the freedom to 
do this as most of their costs are incurred in the development of the drugs, 
while the marginal cost of producing an additional amount of the drugs is 
relatively inexpensive.186  The pharmaceutical companies recoup their 
development cost and make their profits though selling their drugs in wealthier 
nations.187  Allowing foreign sales of drugs to exhaust the pharmaceutical 
companies’ patents could create a secondary market for drugs earmarked to 
third world countries to be resold in the United States.  The drug companies 
would be forced to compete in the U.S. market with their own products, 
driving down profits and ultimately the development of future advances in 
medicine.  Meanwhile, third world populations would be robbed of desperately 
needed medicine. 
Finally, any change from the status quo would harm patent holders who 
previously entered into licenses with the understanding that the articles 
produced and sold abroad would not exhaust their U.S. patent rights.  Since 
 
 183. Yu, supra note 180, at 349. 
 184. TRIPS, supra note 109, art. 31(f) (indicating that where a compulsory license is 
permitted, such use shall be authorized predominately for the domestic market). 
 185. See Vockrodt, supra note 106, at 205 (“[P]harmaceutical firms often engage in the 
practice of international price discrimination.  This allows firms to charge higher prices in 
lucrative markets, like the United States, to recoup the costs of expensive research and 
development, while at the same time providing drugs at lower prices to areas such as sub-Saharan 
Africa, where consumers would not otherwise be able to afford them.”) (footnotes omitted). 
 186. See id. (noting development costs are recouped by charging high prices to citizens of 
developed countries, enabling companies to charge lower costs to citizens of third-world 
countries). 
 187. Id. 
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Jazz Photo I was decided in 2001, patent holders entering into international 
licensing agreements have likely been very much aware that foreign sales did 
not exhaust their U.S. patents rights.188  While in both the Jazz Photo and LG 
Electronic line of cases the argument that foreign sales should not exhaust U.S. 
patents was used as a fall back argument when originally intended methods of 
preventing patent exhaustion were invalidated,189 it is foreseeable that some 
patent holders may have entered into foreign licenses with the specific 
understanding that such licenses would not affect their market within the 
United States. 
CONCLUSION 
As international IP issues are more frequently being litigated due to the 
globalization of business and competition, there is a need for clarity on the 
issue of the whether the foreign sale of patented goods exhausts the patent 
holder’s U.S. patent rights.  While the recent Supreme Court decision in 
Quanta can be interpreted as reigning in attempts by patent holders to retain 
patent rights on articles after such patent holders have already enjoyed the 
benefits of their patent through the first sale of such articles, the court did not 
specifically address whether foreign sales should exhaust U.S patent rights.190  
With LG Electronics, Inc. v. Hitachi, Ltd., at least one district court has found 
that Quanta’s attempt to reign in the exceptions to the doctrine of patent 
exhaustion applied to foreign sales.191  Still at least one other district court has 
found that by failing to address foreign sales, Quanta did not overturn the 
controlling precedent as set by the Jazz Photo line of cases.192 
There are strong policy reasons as to why upon review of the topic, either 
the Federal Circuit or the Supreme Court should find that foreign sales should 
not exhaust U.S. patent rights.  Even with such a finding, cases like LG 
Electronics, Inc. v. Hitachi, Ltd. may not need to be overturned as there may be 
further issues as to whether a licensing agreement entered into on U.S. soil, 
 
 188. Jazz Photo Corp. v. Int’l Trade Comm’n, 264 F.3d 1094, 1105 (Fed. Cir. 2001) (holding 
U.S. patent rights are not exhausted by foreign sales, provided that the first sale of the patent 
occurs outside of the United States). 
 189. Id. at 1101–02 (noting that appellants’ second argument was that the patent right has 
been exhausted as to the pertinent articles and that their first argument was that the activity in 
question constituted permissible repair rather than impermissible reconstruction); LG Elecs., Inc. 
v. Hitachi, Ltd., 655 F. Supp. 2d 1036, 1042 (N.D. Cal. 2009) (noting LG Electronics’ alternative 
argument was that even if the parts replaced substantially embody the patents, precedent 
regarding exhaustion applies only when the first authorized sale of patented items occurred in the 
United States). 
 190. LG Elecs., Inc., 655 F. Supp. 2d at 1044. 
 191. Id. at 1047. 
 192. Fujifilm Corp. v. Benun, No. 05-cv-1863 (KSH), 2009 WL 2232523, at *3 (D.N.J. July 
24, 2009). 
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controlled by U.S. contract law, and with the benefits reaped within the United 
States would constitute an authorized sale under U.S. patent laws.193 
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 J.D., Saint Louis University, 2010; M.B.A., Olin School of Business/Washington University in 
St. Louis, 2005; B.S. in Chemical Engineering, Missouri School of Science and Technology 
(formerly University of Missouri-Rolla), 1999.  I would like to thank Vince Keil for introducing 
me to topic of this article, Professor Efthimios Parasidis (SLU Law) for his guidance and advice 
throughout the writing process, and the St. Louis University Law Journal staff for their careful 
editing.  I especially thank my wife Katrina, as well as the rest of my friends and family for their 
support and encouragement. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
740 SAINT LOUIS UNIVERSITY LAW JOURNAL [Vol. 55:713 
 
